[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 566
Citations 0
Correction
June 2014

Incorrect Value in Table

JAMA Neurol. 2014;71(6):803. doi:10.1001/jamaneurol.2014.1265

In the Viewpoint titled “Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?” published online January 6, 2014, and in the March issue of JAMA Neurology (2014;71[3]:269-270. doi:10.1001/jamaneurol.2013.5486), the Table contained a typographical error in the last column. The value for fingolimod in the composite clinical and radiographic disease activity free status should have been 33%. This article has been corrected online.

×